The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.

Hepatitis-associated aplastic anemia (HAAA) is a variant of severe aplastic anemia (SAA) in which bone marrow failure follows an acute attack of hepatitis. Its pathogenesis is poorly understood. We investigated the prevalence of HAAA among cases of newly diagnosed SAA presenting to our hospital betw...

Full description

Bibliographic Details
Main Authors: Huaquan Wang, Meifeng Tu, Rong Fu, Yuhong Wu, Hong Liu, Limin Xing, Zonghong Shao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4028298?pdf=render
_version_ 1818590715887747072
author Huaquan Wang
Meifeng Tu
Rong Fu
Yuhong Wu
Hong Liu
Limin Xing
Zonghong Shao
author_facet Huaquan Wang
Meifeng Tu
Rong Fu
Yuhong Wu
Hong Liu
Limin Xing
Zonghong Shao
author_sort Huaquan Wang
collection DOAJ
description Hepatitis-associated aplastic anemia (HAAA) is a variant of severe aplastic anemia (SAA) in which bone marrow failure follows an acute attack of hepatitis. Its pathogenesis is poorly understood. We investigated the prevalence of HAAA among cases of newly diagnosed SAA presenting to our hospital between January 1998 and February 2013, and analyzed the clinical and immune characteristics of HAAA and non-hepatitis-associated SAA (non-HASAA) patients. The prevalence of HAAA among cases of SAA was 3.8% (36/949), and the majority of patients (33/36) were seronegative for a known hepatitis virus. Compared with non-HASAA patients, HAAA patients had a larger proportion of CD8+ T cells, a lower ratio of CD4+/CD8+ T cells, and a smaller proportion of CD4+CD25+ regulatory T cells. There was no significant difference in peripheral blood count, bone marrow cellularity, or the number of blood transfusions received between HAAA and non-HASAA patients. HAAA patients had a higher early infection rate and more infection-related mortality in the first 2 years after diagnosis than non-HASAA patients, and their 2-year survival rate was lower. The results demonstrate that HAAA patients have a more severe T cell imbalance and a poorer prognosis than non-HASAA patients.
first_indexed 2024-12-16T10:00:57Z
format Article
id doaj.art-6d9e6c7d13d04a54b085c77fbc2f5bac
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T10:00:57Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6d9e6c7d13d04a54b085c77fbc2f5bac2022-12-21T22:35:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9814210.1371/journal.pone.0098142The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.Huaquan WangMeifeng TuRong FuYuhong WuHong LiuLimin XingZonghong ShaoHepatitis-associated aplastic anemia (HAAA) is a variant of severe aplastic anemia (SAA) in which bone marrow failure follows an acute attack of hepatitis. Its pathogenesis is poorly understood. We investigated the prevalence of HAAA among cases of newly diagnosed SAA presenting to our hospital between January 1998 and February 2013, and analyzed the clinical and immune characteristics of HAAA and non-hepatitis-associated SAA (non-HASAA) patients. The prevalence of HAAA among cases of SAA was 3.8% (36/949), and the majority of patients (33/36) were seronegative for a known hepatitis virus. Compared with non-HASAA patients, HAAA patients had a larger proportion of CD8+ T cells, a lower ratio of CD4+/CD8+ T cells, and a smaller proportion of CD4+CD25+ regulatory T cells. There was no significant difference in peripheral blood count, bone marrow cellularity, or the number of blood transfusions received between HAAA and non-HASAA patients. HAAA patients had a higher early infection rate and more infection-related mortality in the first 2 years after diagnosis than non-HASAA patients, and their 2-year survival rate was lower. The results demonstrate that HAAA patients have a more severe T cell imbalance and a poorer prognosis than non-HASAA patients.http://europepmc.org/articles/PMC4028298?pdf=render
spellingShingle Huaquan Wang
Meifeng Tu
Rong Fu
Yuhong Wu
Hong Liu
Limin Xing
Zonghong Shao
The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
PLoS ONE
title The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
title_full The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
title_fullStr The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
title_full_unstemmed The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
title_short The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
title_sort clinical and immune characteristics of patients with hepatitis associated aplastic anemia in china
url http://europepmc.org/articles/PMC4028298?pdf=render
work_keys_str_mv AT huaquanwang theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT meifengtu theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT rongfu theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT yuhongwu theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT hongliu theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT liminxing theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT zonghongshao theclinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT huaquanwang clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT meifengtu clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT rongfu clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT yuhongwu clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT hongliu clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT liminxing clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina
AT zonghongshao clinicalandimmunecharacteristicsofpatientswithhepatitisassociatedaplasticanemiainchina